An Economic Evaluation of Adjuvant TrastuzumabTherapy in HER 2-Positive Early Breast

Objective: One-year adjuvant trastuzumab therapy increases diseasefree and overall survival in the adjuvant treatment of early HER2positive breast cancer. This study aims to assess the long-term cost-effectiveness of adjuvant trastuzumab treatment in Beijing, Shang-

[1]  M. Fehr,et al.  Cost-effectiveness of trastuzumab in the adjuvant treatment of early breast cancer: a model-based analysis of the HERA and FinHer trial. , 2007, Annals of oncology : official journal of the European Society for Medical Oncology.

[2]  Ann Barrett,et al.  How much will Herceptin really cost? , 2006, BMJ : British Medical Journal.

[3]  D. Parkin,et al.  [Time trends, estimates and projects for breast cancer incidence and mortality in China]. , 2006, Zhonghua zhong liu za zhi [Chinese journal of oncology].

[4]  S. Rabbani,et al.  Effect of Herceptin on the development and progression of skeletal metastases in a xenograft model of human breast cancer , 2005, Oncogene.

[5]  M. Yamaguchi,et al.  [Combination immunotherapy using autologous tumor-stimulated lymphocytes and trastuzumab (Herceptin) for the patients with recurrent breast cancer]. , 2005, Gan to kagaku ryoho. Cancer & chemotherapy.

[6]  E. Kleinerman,et al.  Herceptin Down-Regulates HER-2/neu and Vascular Endothelial Growth Factor Expression and Enhances Taxol-Induced Cytotoxicity of Human Ewing's Sarcoma Cells In vitro and In vivo , 2005, Clinical Cancer Research.

[7]  E. Myers,et al.  Treatment of early stage oral cancer. , 2002, Pennsylvania dental journal.

[8]  Bei-fan Zhou.  [Predictive values of body mass index and waist circumference to risk factors of related diseases in Chinese adult population]. , 2002, Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi.

[9]  Tammy O. Tengs,et al.  One thousand health-related quality-of-life estimates. , 2000, Medical care.

[10]  Kimbroe J. Carter,et al.  Treatment of Early-Stage Breast Cancer in the Elderly , 1998, Medical decision making : an international journal of the Society for Medical Decision Making.

[11]  B. Hillner,et al.  Cost-effectiveness of routine radiation therapy following conservative surgery for early-stage breast cancer. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  B E Hillner,et al.  Efficacy and cost effectiveness of adjuvant chemotherapy in women with node-negative breast cancer. A decision-analysis model. , 1991, The New England journal of medicine.

[13]  Knobf Mt.  Early-stage breast cancer: the options. , 1990, The American journal of nursing.

[14]  J. Haybittle,et al.  Early breast cancer. , 1970, British medical journal.

[15]  Pamela N. Munster,et al.  IN HUMAN BREAST CANCER , 2007 .

[16]  J. Pober,et al.  Cells In Vitro and In Vivo Directly Recognize Allogeneic Endothelial T Cells + Human Effector Memory CD4 , 2007 .